Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wilmette, IL
SEC filing record 1 source field available
Fiscal year end
31 December
Monopar Therapeutics has filed 517 SEC EDGAR filings since 18 Jun 2015

SEC filing history

Showing 1-25 of 517 matching filings.

Per page
25
Current page
1
SCHEDULE 13G/A File 005-94081

SCHEDULE 13G/A filing

Filing date
12 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94081

SCHEDULE 13G/A filing

Filing date
12 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-286244

FORM S-8 POS

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-266828

FORM S-8 POS

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-250046

FORM S-8 POS

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-235790

FORM S-8 POS

Filing date
22 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144/A File 001-39070

144/A filing

Filing date
10 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39070

144 filing

Filing date
07 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2026
Reporting date
30 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2026
Reporting date
26 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
30 Jun 2026
Reporting date
22 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-94081

SCHEDULE 13G filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .